Expression of vascular endothelial growth factor-A, matrix metalloproteinase-9, and extravascular matrix patterns and

Afsun Sahin1, Hayyam Kiratli2, Figen Soylemezoglu3

  • 1Ocular Oncology Service, Department of Ophthalmology, Hacettepe University School of Medicine, Ankara, Turkey.

Abstract

Insights

Increased expression of vascular endothelial growth factor-A (VEGF-A) and matrix metalloproteinase-9 (MMP-9) in posterior uveal melanomas correlates with higher metastasis risk. These factors, along with extravascular matrix patterns (EMP), can aid in prognosis after enucleation.

Area of Science:

  • Ophthalmology
  • Oncology
  • Pathology

Background:

  • Posterior uveal melanoma is a rare intraocular malignancy.
  • Prognostic factors are crucial for patient management and treatment strategies.

Purpose of the Study:

  • To evaluate extravascular matrix patterns (EMP) and the expression of vascular endothelial growth factor-A (VEGF-A) and matrix metalloproteinase-9 (MMP-9) in posterior uveal melanomas.
  • To correlate these findings with histopathologic features and metastatic potential.

Main Methods:

  • Analysis of 100 enucleated posterior uveal melanomas.
  • Immunohistochemical assessment of VEGF-A and MMP-9 expression.
  • Evaluation of EMP using reticulin-stained sections and light microscopy for histopathologic parameters.

Main Results:

  • VEGF-A and MMP-9 expression was detected in 84% and 72% of tumors, respectively.
  • Specific extravascular matrix patterns (loop, arc, parallel) were identified.
  • Significant correlations were found between VEGF-A/MMP-9 expression, tumor characteristics, and metastatic disease development in 14% of patients.

Conclusions:

  • Elevated VEGF-A and MMP-9 expression are associated with an increased incidence of melanoma metastasis.
  • VEGF-A, MMP-9, and EMP serve as independent prognostic indicators for posterior uveal melanoma management post-enucleation.